|
Dr. Fisher is Director of the James P. Wilmot Cancer Center and Director of Cancer Services for Strong Health. He is also an internationally known expert in biological research and treatment of lymphoma and is a nationally renowned cancer clinician, scientist and educator. Dr. Fisher, is the Chief of the Hematology/Oncology Unit in the Department of Medicine and the Samuel E. Durand Professor of Medicine at Strong Memorial and Highland hospital, which together provide comprehensive care for cancer patients throughout Western and Upstate New York.
Dr. Fisher came to Strong Memorial Hospital from the Cardinal Bernardin Cancer Center at Loyola University Stritch School of Medicine in Chicago, where he served as director since 1984. During his tenure at Loyola, he helped create the Cardinal Bernardin Cancer Center and has worked to build a program supported by the National Cancer Institute. He established a state-of-the-art laboratory space for research and led the way to a $35 million facility for cancer prevention, treatment and research.
He earned his medical degree from Harvard Medical School and did his internship and residency in medicine at Massachusetts General Hospital in Boston. Dr. Fisher served as clinical associate in the Immunology Branch of the National Cancer Institute in Bethesda, Maryland and completed an Oncology Fellowship in Medicine.
Dr. Fisher currently serves as chairman of the Lymphoma Committee of the Southwest Oncology Group and is a member of various groups such as the American Society of Clinical Oncology, American Association for Cancer Research, American Society of Hematology, American Joint Committee on Cancer's Lymphoma Task Force, American Association of Immunologists, Clinical Immunology Society, Central Society for Clinical Cancer Research and the American College of Physician Executives. He has authored more than 250 articles and chapters in the national and international publications.
Dr. Fisher's research centers on the biology and treatment of lymphoma, cancers derived from white blood cells, and has led national and international studies on Hodgkin's Disease and Non-Hodgkin's lymphoma.
|
